NDC 58264-0108

D-102

Garlic, Aloe, Mycobacterium Tuberculosis, Eucalyptus Globulus Leaf, Canis Lupus Familiaris Milk, Cow Milk, Rancid Beef, Delphinium Staphisagria Seed, Staphylococcus Epidermidis, Staphylococcus Haemolyticus, Staphylococcus Simulans, Streptococcus Pyogenes, And Sulfur

D-102 is a Sublingual Solution in the Human Otc Drug category. It is labeled and distributed by Dna Labs, Inc.. The primary component is Garlic; Aloe; Mycobacterium Tuberculosis; Eucalyptus Globulus Leaf; Canis Lupus Familiaris Milk; Cow Milk; Rancid Beef; Delphinium Staphisagria Seed; Staphylococcus Epidermidis; Staphylococcus Haemolyticus; Staphylococcus Simulans; Streptococcus Pyogenes; Sulfur.

Product ID58264-0108_9b00d0f8-259b-456e-8b79-25a9f238e441
NDC58264-0108
Product TypeHuman Otc Drug
Proprietary NameD-102
Generic NameGarlic, Aloe, Mycobacterium Tuberculosis, Eucalyptus Globulus Leaf, Canis Lupus Familiaris Milk, Cow Milk, Rancid Beef, Delphinium Staphisagria Seed, Staphylococcus Epidermidis, Staphylococcus Haemolyticus, Staphylococcus Simulans, Streptococcus Pyogenes, And Sulfur
Dosage FormSolution
Route of AdministrationSUBLINGUAL
Marketing Start Date1990-01-01
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameDNA Labs, Inc.
Substance NameGARLIC; ALOE; MYCOBACTERIUM TUBERCULOSIS; EUCALYPTUS GLOBULUS LEAF; CANIS LUPUS FAMILIARIS MILK; COW MILK; RANCID BEEF; DELPHINIUM STAPHISAGRIA SEED; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS SIMULANS; STREPTOCOCCUS PYOGENES; SULFUR
Active Ingredient Strength12 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 58264-0108-1

29.57 mL in 1 BOTTLE, GLASS (58264-0108-1)
Marketing Start Date1990-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 58264-0108-1 [58264010801]

D-102 SOLUTION
Marketing CategoryUnapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date1990-01-01
Inactivation Date2020-01-31

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.